BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 21636866)

  • 1. A synopsis of current haemophilia care in Hong Kong.
    Au WY; Lee V; Kho B; Ling AS; Chan D; Chan EY; Chan GC; Cheung WW; Lau CW; Lee CY; Li RC; Li CK; Lin SY; Mak V; Sun L; Wong KH; Wong R; Yau J; Yuen HL
    Hong Kong Med J; 2011 Jun; 17(3):189-94. PubMed ID: 21636866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilia treatment in the United Kingdom from 1969 to 1974.
    Biggs R
    Br J Haematol; 1977 Apr; 35(4):487-504. PubMed ID: 871406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).
    Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B;
    Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to prophylactic treatment in patients with haemophilia in Germany.
    Miesbach W; Kalnins W
    Haemophilia; 2016 Sep; 22(5):e367-74. PubMed ID: 27353213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Home treatment in hemophilia].
    Pabinger I; Niessner H; Korninger C; Nowotny C; Stain M; Kyrle PA; Lechner K
    Wien Klin Wochenschr; 1987 Nov; 99(22):773-7. PubMed ID: 3124354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The past and future of haemophilia: diagnosis, treatments, and its complications.
    Peyvandi F; Garagiola I; Young G
    Lancet; 2016 Jul; 388(10040):187-97. PubMed ID: 26897598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom.
    Rizza CR; Spooner RJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):929-33. PubMed ID: 6403138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi Province.
    Zhao H; Yang L; Long C; Guo Y; Wu R; Liu X; Qin X; Liang H; Duan Z
    Expert Rev Hematol; 2015 Aug; 8(4):543-50. PubMed ID: 25948487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing pattern of care of boys with haemophilia in western European centres.
    Chambost H; Ljung R;
    Haemophilia; 2005 Mar; 11(2):92-9. PubMed ID: 15810909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia part 1: an introduction.
    Khair K
    Br J Nurs; 2013 Jun 13-26; 22(11):620. PubMed ID: 23899729
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilia care in South Africa: 2004-2007 look back.
    Mahlangu JN;
    Haemophilia; 2009 Jan; 15(1):135-41. PubMed ID: 18700842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
    Dodd C; Watts RG
    Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitor development after changing FVIII/IX products in patients with haemophilia].
    Kocher S; Asmelash G; Makki V; Müller S; Krekeler S; Alesci S; Miesbach W
    Hamostaseologie; 2012; 32 Suppl 1():S39-42. PubMed ID: 22961330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
    Shirahata A; Fukutake K; Higasa S; Mimaya J; Oka T; Shima M; Takamatsu J; Taki M; Taneichi M; Yoshioka A;
    Haemophilia; 2011 Sep; 17(5):771-6. PubMed ID: 21682824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of mild haemophilia: a 30-year single centre experience.
    Tagliaferri A; Di Perna C; Riccardi F; Pattacini C; Rivolta GF; Franchini M
    Haemophilia; 2012 Mar; 18(2):166-74. PubMed ID: 21771207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing bleed frequency and factor concentrate use between haemophilia A and B patients.
    Nagel K; Walker I; Decker K; Chan AK; Pai MK
    Haemophilia; 2011 Nov; 17(6):872-4. PubMed ID: 21342368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synopsis of current care of thalassaemia major patients in Hong Kong.
    Au WY; Lee V; Lau CW; Yau J; Chan D; Chan EY; Cheung WW; Ha SY; Kho B; Lee CY; Li RC; Li CK; Lin SY; Ling AS; Mak V; Sun L; Wong KH; Wong R; Yuen HL
    Hong Kong Med J; 2011 Aug; 17(4):261-6. PubMed ID: 21813892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home treatment of haemophilia and Christmas disease: five years' experience.
    Rizza CR; Spooner RJ
    Br J Haematol; 1977 Sep; 37(1):53-66. PubMed ID: 588479
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemophilia care in Europe: the ESCHQoL study.
    Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
    Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.